Biggest News Aggregation in the World
📰 Amaurosis News

Amaurosis News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Amaurosis. Real-time updates on events, politics, business and more.

VARIANT Receives European Orphan Drug Designation for its Gene Therapy Product Candidate, VAR002, for the Treatment of Both Leber Congenital Amaurosis and Cone-Rod dystrophy

Variant, a company dedicated to developing innovative treatments for inherited eye orphan diseases, announces the decision of the European Commission to grant Orphan Drug Designation (ODD) for VAR002
Kostenloser Wertpapierhandel Florence Portejoie Committee For Orphan Medicinal Products European Commission European Medicine Agency Orphan Drug Designation

European Commission Grants Ocugen Orphan Medicinal Product Designation for Gene Therapy Product Candidate, OCU400, For the Treatment of Both Retinitis Pigmentosa and Leber Congenital Amaurosis

European Commission Grants Ocugen Orphan Medicinal Product Designation for Gene Therapy Product Candidate, OCU400, For the Treatment of Both Retinitis Pigmentosa and Leber Congenital Amaurosis NR2E3), for the treatment of both retinitis pigmentosa (RP) and Leber Congenital amaurosis (LCA). The prevalence of RP in Europe is estimated at approximately 165,000 patients and the prevalence of LCA in Europe is estimated at approximately 40,000 patients. Globally, the number of people suffering from R...
United States Neena Haider Sanjay Subramanian Emmie Twombly Mohamed Genead Professor Of Ophthalmology At Harvard Medical School

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science